4.6 Review

Clinical Ramifications of the MHC Family Fc Receptor FcRn

Journal

JOURNAL OF CLINICAL IMMUNOLOGY
Volume 30, Issue 6, Pages 790-797

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10875-010-9458-6

Keywords

Neonatal Fc receptor; FcRn; Fcgrt; beta(2) microglobulin; therapeutic antibodies; albumin

Categories

Funding

  1. NIH [R01 DK56597, T31 DK07449]

Ask authors/readers for more resources

Introduction Knowledge that antibodies of the IgG isotype have remarkably extended persistence in circulation and are able to pass through cell barriers has substantial implications. While it is well established that so-called neonatal Fe receptor, FcRn, acts throughout life to confer these unusual properties, its ramifications on clinical medicine and therapeutic uses are not broadly appreciated. Scope Here we discuss basic principles and gaps in understanding of FcRn, including its management of IgG antibodies and along with albumin, its impact on use and design of antibody-based therapeutics, and its genetics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available